Project Grant DP2CA301081

Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...
This federal Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $158,500.00 to Trustees of Indiana University, doing business as Indiana University Indianapolis, to develop a novel non-pharmacological strategy to mitigate radiation-induced cardiotoxicity. The research aims to determine optimal parameters for a "protective wounding" approach, where a small subcutaneous incision after radiation exposure can...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The University of Iowa received a $470,000 National Science Foundation (NSF) Project Grant under the Biological Sciences program (CFDA 47.074) to conduct collaborative research on the effect of transcription factor binding on UV lesion accumulation in the human genome. The research aims to determine whether transcription factor binding enhances the frequency of DNA damage or impairs DNA repair, leading to increased mutation rates in those genomic regions. The project will develop innovative...
The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Iowa was awarded a $1.3 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will support preclinical development of use-dependent selective blockers of GluA2-lacking AMPA receptors to prevent noise-induced neurodegeneration. The goal is to investigate medical solutions for the battlefield by transforming health care for service members and the public through innovative biomedical...
The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
The National Institutes of Health (NIH) awarded a $239,363 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant aims to determine the radioprotective efficacy of dietary administration of highly radiation-resistant non-pathogenic fungi in the Drosophila model system. The research will evaluate if consumption of these fungal strains can increase resistance to acute radiation damage across...

The University of Iowa was awarded a $1,354,009 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, which runs from September 1, 2024 to August 31, 2027, aims to develop clinically deliverable RNA strategies for radiation protection. Specifically, the project will leverage the protective qualities of extremophile proteins and new delivery methods to reduce the impact of radiation-induced injuries in cancer patients undergoing radiation therapy, thereby enhancing patient outcomes and quality of life. The research will lay the groundwork for the use of nucleic acid-based therapies for radiation protection.

Generated 5/13/25, 2:07 AM